Serum sodium predicts mortality in patients listed for liver transplantation.
about
Advances in liver transplantation allocation systemsLimitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.Impact of pretransplant hyponatremia on outcome following liver transplantation.Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantationSystematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?Mortality after hospitalization with mild, moderate, and severe hyponatremia.Mortality associated with low serum sodium concentration in maintenance hemodialysis.Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC studyPlasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.Hyponatremia and mortality among patients on the liver-transplant waiting listProfile of hepatic encephalopathy in children with cirrhosis and response to lactulose.MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantationSerum sodium, renal function, and survival of patients with end-stage liver disease.Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.Improving survival in decompensated cirrhosisLiver transplantation in adults: Choosing the appropriate timingModel for end-stage liver disease: end of the first decade.Kidney, pancreas and liver allocation and distribution in the United StatesModerate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis.Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.Current Status of Liver Allocation in the United StatesEvaluation of a scoring system for assessing prognosis in pediatric acute liver failure.Evaluation and management of patients with refractory ascites.Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitisDevelopment of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.Diagnosis and management of hyponatremia in acute illnessAscites improves upon [corrected] serum sodium plus [corrected] model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease.Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.Overview of the indications and contraindications for liver transplantation.Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.Hyponatremia in hospitalized patients: the potential role of tolvaptan.Hyponatraemia: more than just a marker of disease severity?Important predictor of mortality in patients with end-stage liver disease.Tolvaptan for the treatment of liver cirrhosis oedema.Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis.Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.
P2860
Q26766076-F1FA45E3-972A-4621-9C9F-D7CD3AFBFEA0Q33506549-FEF177E3-7484-40A7-9FCE-17E5F65AD546Q33608736-7513C732-5F78-4B09-8BF1-671DCA77F239Q33989198-1F185926-7B10-42CE-B11C-D6E20724D91DQ34254341-10BAE979-C5ED-42D4-BA40-34CDC6F83114Q34469838-5C1D2D01-F8FE-4E5C-978F-80B7E344512CQ34551988-1E4D5C2F-959F-4DE3-84D5-813F67A823D3Q34580775-60081A5C-D4E3-471A-AE89-3363E65B6D9FQ34678891-435C436C-2118-41A6-B6DE-64AF6C7D9CA3Q34789475-83C46455-1350-431C-8C4A-618532178540Q34794004-77B1812B-E26E-46A6-94C0-70869BB94124Q34820619-567D3613-E993-41D8-8413-C0EFF22E1E55Q34996031-A24861BB-976C-43A5-A3DB-16A79A648E5AQ35954077-CD414AB4-65AC-47DF-8653-7DA5C40724ECQ35988332-AC9A1E04-4121-418C-9F62-13230AC9CD74Q36051596-11E54A78-3D3D-463C-BE9E-F46AF2D5BD42Q36090423-09994282-63FB-42B7-9A02-596212892274Q36220176-74E12C40-0862-4D22-AA91-5F6AD0B4F6ACQ36588122-BCDA2FD5-2804-48E3-91D8-520026B41F08Q36591435-85122D2D-21C3-4C8E-8407-54D552578D4AQ36634933-5316C712-8194-4E2A-899D-D32C25B730FBQ36892592-6A5DBA4D-47F4-4999-94B0-3A870C9B7E8BQ36916627-80F36B03-036C-4FE5-B87A-DA2D283F2E7BQ36969100-998F994C-A583-478F-B018-A19DE5937703Q37122130-74C48847-C590-4B7C-A00A-8DD70684FC88Q37212281-72540ECE-ACCD-4985-A838-2629DE2CC45EQ37212974-B6A80DC6-77FA-46D4-9FE9-B50A4AA4B2DFQ37277688-41B44F88-F6D1-4B08-868A-7D408A4D344FQ37343682-B568FD13-6C4E-4267-8E91-2CEF66EE9C7EQ37353473-863C4760-A9E9-4A78-BE9A-101E260F25FFQ37438532-DE39C1EF-D91C-4D91-A67F-4BA6645CDF37Q37636499-6C24AB82-6982-4913-91FA-5A0CF1F2ABB7Q37717937-7FE46BD9-655C-4440-B275-1C3F291666AAQ37789176-56EE6E13-8892-43D9-AF81-3CADBB4C92E3Q37924510-4E6FAF60-B79E-4CDE-BD77-E4227CA99CCAQ38061001-2AD82B50-A6D4-441C-AADC-D623F17B7AF1Q38120248-C7A62ADD-F800-4F96-BA93-707ADDDA3556Q38200108-E425CD91-CB58-4F32-8DE9-15A374DA3D87Q38271966-15FE732D-CE59-4803-B770-7C26A4EF0545Q38449311-E18B6B89-5FE8-4786-9E8A-CEA0D27E45CE
P2860
Serum sodium predicts mortality in patients listed for liver transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Serum sodium predicts mortality in patients listed for liver transplantation.
@en
Serum sodium predicts mortality in patients listed for liver transplantation.
@nl
type
label
Serum sodium predicts mortality in patients listed for liver transplantation.
@en
Serum sodium predicts mortality in patients listed for liver transplantation.
@nl
prefLabel
Serum sodium predicts mortality in patients listed for liver transplantation.
@en
Serum sodium predicts mortality in patients listed for liver transplantation.
@nl
P2093
P356
P1433
P1476
Serum sodium predicts mortality in patients listed for liver transplantation.
@en
P2093
Harry J Rodriguez
John P Roberts
Nathan M Bass
Norah A Terrault
Peter Bacchetti
Scott W Biggins
P356
10.1002/HEP.20517
P407
P577
2005-01-01T00:00:00Z